Staudt discusses Lymphoma research
Posted By Richard Folkers On August 14, 2012 @ 4:10 pm In Scientist Spotlight,lymphoma | Comments Disabled
Louis Staudt, M.D., Ph.D., is the deputy chief of the Metabolism Branch in NCI’s Center for Cancer Research. In this video from March 2012, Staudt discusses the basic biology of targeted therapy for Diffuse B-cell Lymphoma and about ibrutinib, a drug with a high degree of efficacy—and only modest side effects—in the treatment of the ABC form of Diffuse B-cell Lymphoma.
[1]
Article printed from NCI Benchmarks: http://benchmarks.cancer.gov
URL to article: http://benchmarks.cancer.gov/2012/08/staudt-discusses-lymphoma-research/
URLs in this post:
[1] Image: http://www.youtube.com/watch?v=6cot3bU1jKk
Click here to print.